Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.4550
-0.0550 (-10.78%)
Oct 28, 2025, 12:44 PM EDT
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.26 million as of October 29, 2025. Its market cap has decreased by -33.15% in one year.
Market Cap
2.26M
Enterprise Value
-243.06K
Revenue
470.16K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.46
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 2.26M, a decrease of -91.63%. That is a compound annual growth rate of -58.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 2.26M | -38.59% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 337.25M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 320.50M |
| American Oncology Network | 291.52M |